TXG.NASDAQ10x Genomics, INC

Form 4: 10x Genomics Officer Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4 Filing

📋All filings for 10x Genomics, INC
🔒Login to Follow

Benjamin J. Hindson, President and Chief Scientific Officer of 10x Genomics, sold shares of Class A Common Stock to cover tax withholding obligations related to vesting restricted stock units.

Summary

  • On February 24, 2025, Benjamin J. Hindson, President and Chief Scientific Officer of 10x Genomics, sold 4,573 shares of Class A Common Stock.
  • The shares were sold at a price of $11.0656 per share.
  • The transaction was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
  • Following the transaction, Hindson directly owns 335,324 shares of 10x Genomics Class A Common Stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to an insider stock sale for tax purposes. It doesn't convey any strong positive or negative sentiment about the company's performance or future prospects.

Industry Context

This is a routine Form 4 filing, indicating insider activity related to stock sales for tax obligations, which is common among executives receiving stock-based compensation. It doesn't necessarily reflect a change in the executive's confidence in the company.

Stakeholder Impact

  • The sale of shares by an officer could have a minor, temporary impact on the stock price, but is unlikely to have a significant long-term effect.

Key Dates

DateDescription
02/24/2025Date of transaction: Benjamin J. Hindson sold shares of Class A Common Stock.
02/26/2025Date of signature: Eric S. Whitaker, as Attorney-in-Fact for Benjamin J. Hindson, signed the Form 4.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.